Professor of Health Economics & Director, HERC
- Professor of Health Economics, University of Oxford
- Academic, Melbourne School of Population and Global Health
- Honorary, Melbourne Institute of Applied Economic and Social Research
Professor Philip Clarke re-joined HERC in August 2018 after previous appointments at the Universities of Sydney and Melbourne in Australia. He is a Fellow of the Academy of the Social Sciences in Australia (ASSA).
His research interests include developing methods to value the benefits of improving access to health care, health inequalities and the use of simulation models in health economic evaluation. Philip has been involved in the development of the UKPDS Outcomes Model, a health economic simulation model for type 2 diabetes.
The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.
Kent S. et al, (2019), PharmacoEconomics
Incorporating Future Medical Costs: Impact on Cost-Effectiveness Analysis in Cancer Patients.
Tew M. et al, (2019), Pharmacoeconomics, 37, 931 - 941
Transparency in Decision Modelling: What, Why, Who and How?
Sampson CJ. et al, (2019), Pharmacoeconomics
The impact of Medicare part D on income-related inequality in pharmaceutical expenditure
Carvalho N. et al, (2019), International Journal for Equity in Health, 18
Development and Use of Prediction Models for Classification of Cardiovascular Risk of Remote Indigenous Australians.
Tran-Duy A. et al, (2019), Heart, lung & circulation